Calidi Biotherapeutics, Inc.CLDINYSE
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank65
Year-over-Year Change
Year-over-year free cash flow growth rate
Latest
13.61%
↑ 165% vs avg
Percentile
P65
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-20.95%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 13.61% |
| Q2 2025 | 30.83% |
| Q1 2025 | -31.50% |
| Q4 2024 | -9.61% |
| Q3 2024 | -29.09% |
| Q2 2024 | 0.00% |
| Q1 2024 | 27.02% |
| Q4 2023 | 61.32% |
| Q3 2023 | -148.02% |
| Q2 2023 | -68.90% |
| Q1 2023 | 19.64% |
| Q4 2022 | 54.49% |
| Q3 2022 | -190.10% |
| Q2 2022 | -38.68% |
| Q1 2022 | 20.43% |
| Q4 2021 | -88.56% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |